Vaccine-induced immune thrombotic thrombocytopenia (VITT) Webinar Recording

On Thursday 9th September 2021, the Melbourne Medical School Baker Department of Cardiometabolic of Health hosted a Zoom webinar discussing Vaccine-induced immune thrombotic thrombocytopenia (VITT) in patients receiving adenovirus-based vaccines against COVID-19: Mechanisms and status in Australia.

This webinar was chaired by Professor Karlheinz Peter, Head of the Baker Department of Cardiometabolic Health, University of Melbourne.


  • Dr James McFadyen, Haematologist at the Alfred Hospital & Research Fellow at the Baker Heart and Diabetes Institute, Monash and Melbourne University, first mechanistic study on VITT in Australia

VITT: An Australian Perspective

  • Professor Andreas Greinacher, Head of transfusion medicine, University of Greifswald, Germany; expert on heparin-induced thrombocytopenia and first descriptions and mechanistic studies on VITT Mechanisms of Vaccine-induced immune thrombotic thrombocytopenia

Expert panel discussion:

View Webinar